← Back to News

CEACAM5 pre-targeting via click chemistry enables tumor-selective MMAE activation: A first-in-class approach to enhance clinical benefit in targeted therapy

October 24, 2025

Shasqi presented the scientific poster titled, CEACAM5 pre-targeting via click chemistry enables tumor-selective MMAE  activation: A first-in-class approach to enhance clinical benefit in targeted therapy, on October 24, 2025 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston, MA.

View the abstract here.

Want to stay up to date on our news? 
Follow us on LinkedIn